| A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects (NCT05924321) | Ferring Pharmaceuticals | 2023-05-25 |
| 64Cu-GRIP B in Patients With Advanced Malignancies (NCT05888532) | Rahul Aggarwal | 2023-05-25 |
| SB17170 Phase1 Trial in Healthy Volunteer (NCT05795192) | SPARK Biopharma | 2023-05-24 |
| Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS) (NCT05122767) | The Aurum Institute NPC | 2023-05-24 |
| A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects. (NCT06143423) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-05-24 |
| A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors (NCT05907980) | Chugai Pharmaceutical | 2023-05-24 |
| CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms (NCT06593145) | FamiCordTx | 2023-05-24 |
| A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553 (NCT06105255) | InventisBio Co., Ltd | 2023-05-24 |
| Prospective Comparison of the Effect on Antiadhesive Barriers During Thyroid Surgery (NCT05851560) | National Taiwan University Hospital | 2023-05-24 |
| Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma (NCT05734066) | Jazz Pharmaceuticals | 2023-05-23 |
| FOG-001 in Locally Advanced or Metastatic Solid Tumors (NCT05919264) | Parabilis Medicines, Inc. | 2023-05-23 |
| A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects (NCT05942625) | Hansoh BioMedical R&D Company | 2023-05-23 |
| The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 (NCT05829057) | Zhejiang University | 2023-05-23 |
| HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT05553639) | Hookipa Biotech GmbH | 2023-05-23 |
| Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel (NCT05794958) | Stanford University | 2023-05-23 |
| Study of PYX-106 in Solid Tumors (NCT05718557) | Pyxis Oncology, Inc | 2023-05-23 |
| Combination Therapy in Cancers With Mutations in DNA Repair Genes (NCT05694715) | University of California, San Francisco | 2023-05-23 |
| Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors (NCT05976906) | Zhejiang University | 2023-05-23 |
| A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma (NCT05783921) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-05-23 |
| A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of HBM1020 in Subjects With Advanced Solid Tumors (NCT05824663) | Harbour BioMed US, Inc. | 2023-05-23 |
| An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy (NCT05658029) | Matthew Bruehl | 2023-05-23 |
| Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors (NCT05868174) | Telix Pharmaceuticals (Innovations) Pty Limited | 2023-05-23 |
| Dose Escalation Study of Kylo-0603 in Healthy Subjects (NCT06365580) | Kylonova (Xiamen) Biopharma co., LTD. | 2023-05-23 |
| GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma (NCT05650749) | Stephan Grupp MD PhD | 2023-05-23 |
| To Compare the Pharmacokinetics and Pharmacodynamics of HR20014, INS068 and INS062 After Single Subcutaneous Injection in Healthy Subjects (NCT05887895) | Jiangsu HengRui Medicine Co., Ltd. | 2023-05-23 |
| Relative Bioavailability of a New Presentation of Apraglutide Versus the Reference Formulation (NCT06002555) | VectivBio AG | 2023-05-23 |
| Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial (NCT05030298) | Mayo Clinic | 2023-05-23 |
| A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets (NCT05868057) | Jiangsu HengRui Medicine Co., Ltd. | 2023-05-23 |
| Phase IB/II of CPX-351 for Relapse Prevention in AML (NCT04990102) | Georgetown University | 2023-05-22 |
| A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566 (NCT05844735) | Sanofi | 2023-05-22 |
| Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654 (NCT06389955) | Sumitomo Pharma America, Inc. | 2023-05-22 |
| A Gene Transfer Study to Evaluate the Safety, Tolerability and Efficacy of SRP-6004 in Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2B/R2 (LGMD2B/R2, Dysferlin [DYSF] Related) (NCT05906251) | Sarepta Therapeutics, Inc. | 2023-05-22 |
| A Study to Investigate the Absorption, Metabolism and Excretion of [14C]-BGB-11417 (NCT05844111) | BeiGene | 2023-05-22 |
| Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma (NCT05798455) | Tabriz University of Medical Sciences | 2023-05-22 |
| A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge (NCT05884242) | Janssen Research & Development, LLC | 2023-05-22 |
| Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma (NCT04972942) | New York Medical College | 2023-05-22 |
| Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations (NCT05293626) | Neurophth Therapeutics Inc | 2023-05-22 |
| Evaluation of Renal Protection Of Dexmedetomidine Versus Midazolam As a Sedative For Septic Patients In Intensive Care Unit (NCT05903963) | Minia University | 2023-05-22 |
| A Mouthwash Medicine for the Reduction or Prevention of Mouth Ulceration Caused by Radiotherapy for Head and Neck Cancer (NCT06669390) | VasoDynamics Ltd | 2023-05-22 |
| Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer (NCT05411094) | National Cancer Institute (NCI) | 2023-05-22 |
| A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion (NCT05923515) | Jemincare | 2023-05-22 |
| EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) (NCT06923761) | Grey Wolf Therapeutics | 2023-05-21 |
| Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss (NCT06333600) | Sohag University | 2023-05-20 |
| Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple Myeloma (NCT05857982) | Second Affiliated Hospital of Soochow University | 2023-05-20 |
| Clinical Efficacy of Local Delivery of Minocycline and Hyaluronan Gel to Treat Periodontitis in Diabetic Patients (NCT06997731) | Kafrelsheikh University | 2023-05-20 |
| The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma (NCT05841550) | Oslo University Hospital | 2023-05-19 |
| A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects (NCT05895565) | Pulmongene Ltd. | 2023-05-19 |
| REward Processing And Citalopram Study (NCT06017037) | University of Oxford | 2023-05-19 |
| Study of PAT in Patients With Solid Tumor Cancers (NCT05338658) | Masonic Cancer Center, University of Minnesota | 2023-05-19 |
| Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study (NCT05872958) | AstraZeneca | 2023-05-19 |
| A Study of Diclofenac Gel in Women With Primary Dysmenorrhea (NCT05752526) | Daré Bioscience, Inc. | 2023-05-19 |
| Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease (NCT05894343) | MeiraGTx, LLC | 2023-05-19 |
| Gene Therapy for Diabetic Macular Edema (NCT05916391) | Frontera Therapeutics | 2023-05-19 |
| Safety and Clinical Activity of Itolizumab in aGVHD (NCT05823675) | Biotech Pharmaceutical Co., Ltd. | 2023-05-19 |
| Phase 1 Study Into Pharmacokinetics and Food Effect of Vapendavir in Healthy Participants and Participants With COPD (NCT05962645) | Altesa Biosciences, Inc. | 2023-05-19 |
| A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors (NCT05830045) | Qilu Pharmaceutical Co., Ltd. | 2023-05-19 |
| A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (NCT05683171) | M.D. Anderson Cancer Center | 2023-05-19 |
| Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss (NCT06090318) | Rain Oncology Inc | 2023-05-19 |
| The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors (NCT05836948) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-05-18 |
| A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer (NCT05908734) | Janssen Research & Development, LLC | 2023-05-18 |
| Macrophage Regulation of Ozone-Induced Lung Inflammation (NCT05773001) | Robert Tighe, MD | 2023-05-18 |
| The Safety, Tolerability and Pharmacokinetic Study of RAY1225 (NCT05835752) | Guangdong Raynovent Biotech Co., Ltd | 2023-05-18 |
| Siplizumab in T1DM (NCT05574335) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-05-18 |
| A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants (NCT05899738) | Bristol-Myers Squibb | 2023-05-18 |
| Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer (NCT05422794) | National Cancer Institute (NCI) | 2023-05-18 |
| Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment (NCT05580861) | Assistance Publique - Hôpitaux de Paris | 2023-05-17 |
| A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With TTX-381 for the Ocular Manifestations Associated With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease (NCT05791864) | Tern Therapeutics, LLC | 2023-05-17 |
| A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults (NCT05901636) | Janssen Vaccines & Prevention B.V. | 2023-05-17 |
| A Study to Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healthy Subjects (NCT05974969) | Biocad | 2023-05-17 |
| SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy (NCT05586581) | Yale University | 2023-05-17 |
| A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer (NCT05678010) | Memorial Sloan Kettering Cancer Center | 2023-05-17 |
| Study of VSA001 Injection in Chinese Healthy Adult Volunteers (NCT05757596) | Visirna Therapeutics HK Limited | 2023-05-17 |
| Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine (NCT05857566) | Response Pharmaceuticals | 2023-05-16 |
| Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention Following an Acute Knee Injury (NCT05204836) | University of Calgary | 2023-05-16 |
| A Study to Evaluate the Safety and Tolerability of ILB-202 (NCT05843799) | ILIAS Biologics Inc. | 2023-05-16 |
| A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes (NCT05791201) | Vertex Pharmaceuticals Incorporated | 2023-05-16 |
| BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors (NCT05869240) | Betta Pharmaceuticals Co., Ltd. | 2023-05-16 |
| Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects (NCT05844293) | Sirnaomics | 2023-05-16 |
| A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B) (NCT05319730) | Merck Sharp & Dohme LLC | 2023-05-16 |
| A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations (NCT05588141) | National Cancer Institute (NCI) | 2023-05-16 |
| A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1) (NCT05230459) | AskBio Inc | 2023-05-15 |
| Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen (NCT05736224) | Yale University | 2023-05-15 |
| A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants. (NCT05878522) | Pfizer | 2023-05-15 |
| A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects (NCT05819710) | Taisho Pharmaceutical Co., Ltd. | 2023-05-15 |
| A Study of BRII-297 in Healthy Adult Subjects (NCT05845840) | Brii Biosciences Limited | 2023-05-15 |
| A Relative Bioavailability Study of HRS9531 in Healthy Subjects (NCT05893576) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2023-05-15 |
| Colonoscopic Sucralfate Spray in Prevention of Delayed Polypectomy Bleeding (NCT05817656) | National Cheng-Kung University Hospital | 2023-05-15 |
| Acetaminophen Before Surgery Lowers Postop Pain in Pediatric Solid Tumor Patients (ERAS) (NCT07095816) | Nanjing Children's Hospital | 2023-05-15 |
| Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia (NCT05890794) | AM-Pharma | 2023-05-15 |
| Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study (NCT05447286) | Yale University | 2023-05-15 |
| Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica (NCT05828212) | Zhejiang University | 2023-05-15 |
| Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001 (NCT05800873) | Everest Medicines (China) Co.,Ltd. | 2023-05-15 |
| Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus (NCT05846347) | Zhejiang University | 2023-05-15 |
| A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men (NCT05870670) | Novo Nordisk A/S | 2023-05-15 |
| [14C] Study on Mass Balance and Biotransformation of STI-1558 in Healthy Chinese Adult Male Subjects (NCT05754411) | Zhejiang ACEA Pharmaceutical Co. Ltd. | 2023-05-15 |
| A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA) (NCT05839626) | Sanofi | 2023-05-15 |
| DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT05824585) | Dizal Pharmaceuticals | 2023-05-15 |
| A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function (NCT05406219) | Bayer | 2023-05-15 |
| A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants. (NCT05858788) | Sanofi | 2023-05-15 |
| Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors (NCT05775406) | Kymera Therapeutics, Inc. | 2023-05-15 |